Sabina Kersting

γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia

Wouter Scheper, Suzanne van Dorp, Sabina Kersting et al. · Leukemia · 2013 · 183 citations

Life Sciences, Cancer Biology, Immunology +11

Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment

Iris de Weerdt, Tom Hofland, Renate de Boer et al. · Blood Advances · 2019 · 107 citations · Full text

Life Sciences, Hematology, Immunology +17

Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival

Sabina Kersting, H A Koomans, Ronald J. Hené et al. · Bone Marrow Transplantation · 2007 · 106 citations

Medicine, Hematology, Nephrology +15

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Medicine, Internal Medicine, Oncology +14

Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial

Arnon P. Kater, Mark‐David Levin, Julie Dubois et al. · The Lancet Oncology · 2022 · 58 citations · Full text

Medicine, Hematology, Pharmacotherapy +14